Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Results: A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating CPI-0610 with and without ruxolitinib in hematologic and myeloproliferative malignancies; study complete…
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Case-Control Study of Pesticides and Childhood Leukemia
This update reports the completion of a case-control study sponsored by the National Cancer Institute examining the association between pest…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Action of the Vidaza on the Atrial Fibrillation
This clinical trial update reports the results of a completed study evaluating the effect of Vidaza (azacitidine) on atrial fibrillation in …
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
A completed clinical trial update detailing a genome expression study in leukemia, multiple myeloma, and lymphomas (Hodgkin and Non-Hodgkin)…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine [Phase 1]
Phase 1 open-label bioavailability study comparing pharmacokinetics of oral cladribine with intravenous cladribine. The study status is TERM…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
This update reports long-term follow-up of patients who participated in Children's Oncology Group studies; the trial is currently active but…
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Exercise Prehabilitation Among Older Patients With Hematological Malignancies Preparing For CAR-T Cell Immunotherapy [NA]
A completed clinical trial evaluating exercise prehabilitation in older patients with hematological malignancies preparing for CAR-T cell im…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide [Phase 2]
Phase 2 trial evaluating HLA-mismatched unrelated donor hematopoietic cell transplantation with post-transplantation cyclophosphamide is act…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: HeartPhone Cancer Survivors Trial 2019 [Phase 1, Phase 2]
The HeartPhone Cancer Survivors Trial (Phase 1/2) sponsored by Penn State University was terminated; results have been posted for breast can…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Cardiovascular Effects of CART Cell Therapy
A completed clinical trial update investigates the cardiovascular effects of CAR-T cell therapy in leukemia and lymphoma patients.
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Assessment of Antithrombin III, Protein C, Protein S and D-dimer in Acute Leukemia
A completed clinical trial evaluating coagulation markers (antithrombin III, protein C, protein S, and D-dimer) in patients with acute leuke…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Removing Transfusion Dependence as a Barrier to Hospice Enrollment [NA]
A completed clinical trial update indicates that transfusion dependence was removed as a barrier to hospice enrollment for patients with hem…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Tegavivint for the Treatment of Relapsed or Refractory Leukemia [Phase 1]
Phase 1 trial update for tegavivint in relapsed or refractory leukemia; the study is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Strength Training Exercises to Minimise Late Effects of Childhood Leukaemia or Lymphoma Among Adolescents [NA]
This completed clinical trial investigates strength training to minimize late effects in adolescents who survived childhood leukemia or lymp…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe. [Phase 1, Phase 2]
A Phase 1/2 clinical trial is testing an improved dose of UM171 to enhance the effectiveness and safety of cord blood transplantation; recru…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Impact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of the Department of Blood Diseases [NA]
Completed clinical trial assessing the impact of supportive care on the hospitalization experience for patients with acute leukemia undergoi…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation [Phase 1, Phase 2]
Phase 1/2 trial evaluating GVHD prophylaxis with post-transplant cyclophosphamide plus sirolimus and VIC-1911 in myeloablative peripheral bl…
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia [Phase 1]
A Phase 1 feasibility and safety study of dual CD19/CD22 CAR-T cell therapy for CD19+CD22+ leukemia, with the trial currently active but not…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Membrane Target Detection for Leukemia Treatment
A clinical trial from the University of Missouri-Columbia is investigating membrane target detection as a treatment approach for leukemia an…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Thiotepa Plus Fludarabine+ Melphalan as the Preparative Regime for Alternative Donor Transplantation [Phase 2]
Phase 2 trial results evaluating thiotepa, fludarabine, and melphalan as a preparative regimen for alternative donor transplantation in leuk…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Larotrectinib in Treating Patients With Previously Untreated TRK Fusion Solid Tumors and TRK Fusion Relapsed Acute Leukemia [Phase 2]
Phase 2 trial evaluating larotrectinib for TRK fusion cancers across solid tumors and TRK fusion relapsed acute leukemia in pediatric patien…
-
CLINICAL_TRIALS trial_result · 2025-10-27Clinical Trial Update: Resiliency in Older Adults Undergoing Bone Marrow Transplant
A completed clinical trial update from Johns Hopkins on resiliency in older adults undergoing bone marrow transplant for hematologic cancers…
-
CLINICAL_TRIALS trial_result · 2025-10-23Clinical Trial Update: Methadone as an Alternative Treatment for Children Underdoing HSCT [Phase 3]
Phase 3 trial evaluating methadone as an alternative treatment for children undergoing hematopoietic stem cell transplantation; the study is…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children [Phase 1]
Phase 1 pediatric trial update evaluating carfilzomib with cyclophosphamide and etoposide for relapsed or refractory solid tumors and leukem…
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating CPI-0610 with and without ruxolitinib in patients with hematologic and myeloproliferative malignancies. …